Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2013; 110(01): 01
DOI: 10.1160/TH13-05-0357
DOI: 10.1160/TH13-05-0357
T&H Insights
Procoagulants for management of bleeding with the new oral anticoagulants
Further Information
Publication History
Received:
02 May 2013
Accepted:
02 May 2013
Publication Date:
30 November 2017 (online)
Insight on: Perzborn et al. Thromb Haemost 2013; 110: 162-172.
-
References
- 1 Perzborn E, Gruber A, Tinel H. et al. Reversal of rivaroxaban anticoagulation by haemostatic agents in rats and primates. Thromb Haemost 2013; 110: 162-172.
- 2 Eerenberg ES, Kamphuisen PW, Sijpkens MK. et al. Reversal of rivaroxaban and dabigatran by pro thrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation 2011; 124: 1573-1579.
- 3 Godier A, Miclot A, Le Bonniec B, Durand M. et al. Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model. Anesthesiology 2012; 116: 94-102.
- 4 Zhou W, Zorn M, Nawroth P. et al. Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxaban. Stroke 2013; 44: 771-778.
- 5 Southworth MR, Reichman ME, Unger EF. Dabi gatran and postmarketing reports of bleeding. N Engl J Med 2013; 368: 1272-1274.
- 6 Weitz JI, Quinlan DJ, Eikelboom JW. Peripro cedural management and approach to bleeding in patients taking dabigatran. Circulation 2012; 126: 2428-2432.